Cafepharma Today

July 26 2024 - Eisai and Biogen's Alzheimer's med Leqembi turned down in Europe
Eisai and Biogen's Alzheimer's med Leqembi turned down in Europe
BMS gets Q2 beat, raises full-year guidance as cost-cutting initiative continues
Big Pharma appears to be unfazed by IRA drug price negotiations
Indivior reaches $86 million opioid settlement with US states
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Icahn Wins, But Bristol Isn't A Total Loser Either
Forbes
Monday, October 6, 2008 - 10:56am
tags:
Dr. Reddy's Falls After Report on Diabetes Drug Delay
Bloomberg
Monday, October 6, 2008 - 10:27am
tags:
Genentech and OSI say Avastin and Tarceva miss main goal in late-stage clinical trial
Yahoo/AP
Monday, October 6, 2008 - 9:31am
tags:
BioSante Pharma Reaquires Elestrin
Seeking Alpha
Monday, October 6, 2008 - 9:31am
tags:
Discovery Labs: The Next Biotech Buy?
Seeking Alpha
Monday, October 6, 2008 - 9:30am
tags:
[video]Lilly/ImClone Deal
CNBC
Monday, October 6, 2008 - 9:29am
tags:
J&J biologic Crohn's disease drug outperforms standard immune-damping pill in company study
Yahoo/AP
Monday, October 6, 2008 - 9:20am
tags:
Momenta Pharma Investors In Waiting Game on Enoxaparin
Seeking Alpha
Monday, October 6, 2008 - 9:19am
tags:
Bayer's Riociguat Lung Drug Shows Exercise Benefit in Study
Bloomberg
Monday, October 6, 2008 - 9:18am
tags:
Lilly Agrees to Buy ImClone for $6.5 Billion
Bloomberg
Monday, October 6, 2008 - 9:12am
tags:
Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years
PR NewsWire
Sunday, October 5, 2008 - 2:11pm
tags:
China Biotech in Review: Deals and Earnings
Seeking Alpha
Sunday, October 5, 2008 - 2:10pm
tags:
Multi-drug 'polypill' finally to tackle heart problems
NewScientist
Sunday, October 5, 2008 - 2:03pm
tags:
Israeli device could replace anticoagulants in surgery
Israel21c, Israel
Sunday, October 5, 2008 - 2:02pm
tags:
R&D for drug firms
Fort Worth Star Telegram, TX
Sunday, October 5, 2008 - 1:47pm
tags:
A Shareholder Of Medicis Pharmaceutical Corp. (NYSE MRX) Has Filed A Class Action Lawsuit Against Medicis Pharmaceutical Corp. For Allegedly Issuing Materially Inaccurate Financial Statements
PR Inside
Sunday, October 5, 2008 - 1:44pm
tags:
Eli Lilly, Jubilant In Joint Venture
Top News, India
Sunday, October 5, 2008 - 1:42pm
tags:
Speculating on Genzyme
CNBC
Saturday, October 4, 2008 - 3:52pm
tags:
Investor Alert: KGS Notifies Medicis Pharmaceutical Purchasers With Losses Greater Than $300,000, of Lead Plaintiff Application Deadline in Securities Class Action Lawsuit - MRX
Yahoo
Saturday, October 4, 2008 - 3:50pm
tags:
Panacea Biotec enters into alliance with PharmAthene
Moneycontrol, India
Saturday, October 4, 2008 - 3:48pm
tags:

Pages

Latest CP Wire Articles

PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility
Eastman introduces new excipient to formulate poorly soluble API

Latest Pharmagather Articles

Crafting Effective, Patient-Centric Channel Strategies
Drug Channels
Gross-to-Net Bubble Update: 2023 Pricing Realities at 10 Top Drugmakers
Drug Channels
Optimizing Product Commercialization in Today’s IDN Environment
Drug Channels
PBM Power: The Gross-to-Net Bubble Reached $334 Billion in 2023—But Will Soon Start Deflating
Drug Channels
At the Breaking Point: The Unsustainable Future of Government Drug Discount Programs
Drug Channels
Who Will Pay for Prescription Drugs in 2032: Four Takeaways from the New Government Forecasts
Drug Channels
Breaking Down Medication Access and Affordability Barriers
Drug Channels
Drug Channels News Roundup, June 2024: Cordavis Humira Update, OptumRx’s New Biosim Biz, Generic Drugs' Wild Ride, IRA Predictions, and Dr. G on Med School
Drug Channels
Meet the Four Executives Headlining the Drug Channels Leadership Forum
Drug Channels

Latest Jobs

Account Executive - Hospice
Freeman, Missouri, 64746
Agape Care Group
Account Executive - Hospice
Wellington, Missouri, 64097
Agape Care Group
Account Executive - Hospice
Napoleon, Missouri, 64074
Agape Care Group
Healthcare Sales Professional
Denton, Texas, Texas
Tris Pharma
Psychiatry Account Manager - Santa Monica, CA
Santa Monica, California
Lundbeck
Senior Account Consultant, Durysta - San Diego, CA
San Diego, California, California
AbbVie
Senior Account Consultant, Retina - Hartford, CT
New Haven, Connecticut, Connecticut
AbbVie
Oncology Specialist - New York City
New York City, New York
AbbVie
Associate Director, Strategic Account Manager, Southern California
Los Angeles, California, California
AbbVie
Oncology Specialist - LA West
Santa Monica, California
AbbVie
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information